Company / SG&A per Share
Nuo Therapeutics, Inc. SG&A per Share History
FY2011-FY2017 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$0.39
FY2017
5-year range
$0.03 / $0.39
FY2013-FY2017
Trend
+1370.4%
vs FY2016
Sector context
Sector data unavailable
Latest sector comparison
What the data says
SG&A per Share changed +1370% YoY in FY2017, a notable deviation from the 6-year average annual change of +222%.
Based on SEC 10-K filings.
0.39 in FY2017 with a 5-year CAGR of +30.8%.
Increased from $0.07 to $0.39 over the past 2 years.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- +61.0%
- 5-Year CAGR
- +30.8%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2017, sg&a per share increased 1370.4% year-over-year.
- Lowest sg&a per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -45.34 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2017 | $0.39 | +1370.4% |
| FY2016 | $0.03 | -63.5% |
| FY2015 | $0.07 | -22.2% |
| FY2014 | $0.09 | +27.4% |
| FY2013 | $0.07 | -28.0% |
| FY2012 | $0.10 | +50.4% |
| FY2011 | $0.07 | - |
As of FY2017 · SEC 10-K · Updated Jun 29, 2026